INCYTE CORP 4

Steven H. Stein (CMO & Head of Late-Stage Dev., Incyte Corp) sold 1,877 INCY common shares for about $215K and received new RSU, performance share, and stock option awards on July 16, 2026.

On July 16, 2026, Steven H. Stein, CMO & Head of Late-Stage Development of Incyte Corp, sold 1,877 shares of common stock at $114.73 per share for proceeds of approximately $215,300, while simultaneously receiving equity compensation grants consisting of 9,798 restricted stock units, 24,496 performance shares (each eligible to pay out up to 200% of one common share based on three-year TSR performance), and 42,298 employee stock options with a $116.65 exercise price that vest over four years in 37 installments. Following these transactions, his directly held common stock position increased to 30,916 shares (excluding the separate unvested RSUs and performance units referenced in the footnotes), and he also holds the newly granted performance shares and options. The RSUs vest 25% per year over four years, the performance shares cliff-vest on the third anniversary of grant subject to performance and continued service, and the options vest 25% after one year with the remainder vesting monthly thereafter over three years, indicating a primarily compensation- and retention-driven transaction set with a relatively modest open-market sale.

Filing Facts

CIK

879169

Ticker

INCY

Form

4

Source Type

fda

Accession

0001673776-26-000019

Alert Tier

6